Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07060391Phase 3Not yet recruiting
Phase 3, randomised, open-label trial (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Alzheimer's Disease Assessment Scale-Cognitive Subscale at 48 weeks. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07060391.